Illumina Launches Accelerator Program for Startups Working on NGS | GenomeWeb

NEW YORK (GenomeWeb News) – Illumina today said that it has launched a business accelerator program intended to help startups and early-stage companies working on next-generation sequencing applications.

The firm has partnered with technology investor Yuri Milner, who has invested in Facebook, Twitter, Spotify, and 23andMe, among other tech startups, and Silicon Valley Bank to provide funding and guidance for program participants.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.